#United States #biotechnology #INOVIO #Plymouth Meeting #DNA medicine

INOVIO's Participation in the Stephens Biotechnology Virtual Conference

INOVIO Pharmaceuticals, Inc., known for its groundbreaking work in DNA medicines, has announced its upcoming involvement in the Stephens Biotechnology Virtual Fireside Chat Conference. This event is slated for November 4, 2025, from 3:00 PM to 3:50 PM ET. The company's management team will take part in this insightful session to discuss their latest advancements in biotechnology.

Focused on Innovative Healthcare Solutions

INOVIO specializes in developing and commercializing innovative DNA medicines aimed at treating and preventing HPV-related illnesses, various cancers, and infectious diseases. Their proprietary technology empowers the human body to create its own tools to combat these health challenges, showcasing a revolutionary approach in medical treatment. During this virtual conference, INOVIO will highlight how their technological advancements are set to transform patient care.

One-on-One Investor Meetings

In addition to the main session, INOVIO's leadership team will conduct personalized one-on-one meetings with select investors. This opportunity allows for deeper discussions regarding the company’s strategic plans, ongoing projects, and future growth prospects in the ever-evolving biotechnology landscape. Investors and interested stakeholders can connect with their Stephens representative to secure their participation.

Direct Engagement with Thought Leaders

The virtual format of this event enables a broad audience of investors and industry professionals to engage directly with INOVIO's leadership. Despite the lack of a replay or transcript, the live nature of the fireside chat ensures that attendees can glean firsthand insights into INOVIO’s innovations and strategic vision.

About INOVIO Pharmaceuticals

Founded with a mission to change the landscape of infectious disease and cancer treatment, INOVIO has positioned itself as a frontrunner in the biotechnology industry. The company leverages its advanced DNA delivery systems to develop drugs that not only treat existing conditions but also help in disease prevention. With their cutting-edge research, INOVIO remains dedicated to improving global health outcomes.

For more detailed information about INOVIO and their pioneering work in biotechnology, please visit their official website at www.inovio.com.

Media and Investor Contact

For media inquiries, reach out to Jennie Willson at (267) 429-8567 or via email at [email protected]. Investors can contact Peter Vozzo of ICR Healthcare at (443) 213-0505 or at [email protected] for further information.

As INOVIO continues to push the boundaries of medical science, their upcoming discussions at the Stephens Biotechnology Virtual Conference will provide notable insights into the future of disease management and treatment methodologies.